Reenita Das, Partner, Frost & Sullivan,
Kamaljit Behera, Industry Analyst, Frost & Sullivan,
Neil Jordan, Worldwide General Manager, Health Industry, Microsoft,
Kay Eron, General Manager, Health and Life Sciences, Intel,
Keith Bigelow, General Manager, Analytics, GE Healthcare
Expert Insight on the Future of Healthcare
2018 will be a tipping point for mainstream adoption of popular digital health tech/solutions (e.g., artificial intelligence, mHealth/wearables, telehealth, Big Data analytics, and robotics) and the transition of noble technologies from research/proof-of-concept to actionable healthcare and clinical applications (e.g., blockchain and cancer immunotherapy products).
Data monetization will unleash the power of patient data to achieve better outcomes across the healthcare value chain. Digital transformation of patient monitoring along with data hubs using cell phone networks will drive health revenue, further reducing hospital inpatient census. There will be growing awareness of current inefficiencies in healthcare delivery; for example, poor utilization of operating theaters. Optimization of resources, care coordination employing technology-based platforms, and products or services that improve the efficiency of healthcare delivery will be in demand. Highly capitalized players like Amazon, Alibaba, and Google will reshape whole segments of healthcare, revolutionizing and simplifying patient experiences and patient empowerment.
Frost & Sullivan’s experts are predicting another year of big disruptions, transformations and innovations as the healthcare industry continues to overhaul outmoded business models. This annual forecast aims to help stakeholders understand key issues affecting the healthcare industry globally. Advances in areas ranging from cancer immunotherapy products to blood testing, as well as the convergence of cutting-edge technology such as artificial intelligence and blockchain, will help shape the healthcare industry into a much-anticipated, value-based care paradigm. The webinar will identify market risks and opportunities for stakeholders developing solutions connected to the pharmaceutical, biotechnology, medical technologies, diagnostics and healthcare IT sectors that can impact industry participants